Trials / Completed
CompletedNCT04764643
The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy
The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy: a Prospective, Non-inferiority, Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Xijing Hospital of Digestive Diseases · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Lugol chromoendoscopy is essential in detecting and characterizing squamous cell carcinoma of esophagus. Esophageal irritating symptom has been reported as an common adverse event, which could be alleviated by sodium thiosulfate solutions. However, sodium thiosulfate was not widely available. N-acetylcysteine has been previously used as a mucolytic reagent, we propose that it may also be used to alleviate irritating symptoms caused by Lugo's chromoendoscopy. A prospective, non-inferior, randomized double-blind clinical trial was designed to study the efficacy of N-acetylcysteine solutions in relieving esophageal discomfort .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | N-acetylcysteine solution | use N-acetylcysteine solution to alleviate esophageal irritation caused by Lugol's chromoendoscopy |
| DRUG | sodium thiosulfate solution | use sodium thiosulfate solution to alleviate esophageal irritation caused by Lugol's chromoendoscopy |
Timeline
- Start date
- 2020-02-01
- Primary completion
- 2021-04-30
- Completion
- 2021-05-31
- First posted
- 2021-02-21
- Last updated
- 2023-01-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04764643. Inclusion in this directory is not an endorsement.